CLINICAL_TRIALS trial_result · 2024-04-08

Clinical Trial Update: Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed WHO Grade IV Unmethylated Glioma [Phase 2]

Phase 2 trial evaluating an immunotherapy targeting cytomegalovirus in newly diagnosed unmethylated glioma (glioblastoma) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Mustafa Khasraw, MBChB, MD, FRCP, FRACP | Conditions: Glioblastoma | Phase 2 | Status: TERMINATED | Results posted: 2024-04-08